Ulcerative colitis during dupilumab therapy in a patient with atopic dermatitis

J Dermatol. 2023 Dec;50(12):e420-e421. doi: 10.1111/1346-8138.16928. Epub 2023 Aug 25.

Authors

Mariko Seishima¹, Makiko Sasaki¹, Hideki Hachiken¹, Takuma Furukawa¹, Nobuaki Yagi², Shigeyuki Sugie³

Affiliations

¹ Department of Dermatology, Asahi University Hospital, Gifu, Japan.
² Department of Gastroenterology, Asahi University Hospital, Gifu, Japan.
³ Department of Pathology, Asahi University Hospital, Gifu, Japan.

PMID: 37622193
DOI: 10.1111/1346-8138.16928

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal / adverse effects
Antibodies, Monoclonal, Humanized / adverse effects
Colitis, Ulcerative* / drug therapy
Dermatitis, Atopic* / complications
Dermatitis, Atopic* / drug therapy
Humans
Severity of Illness Index
Treatment Outcome

Substances

dupilumab
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal